Skip to content

Medical emergency? What to do

Only 1 in 5 women in developing world receive effective cervical cancer screening

3-RXPublished June 17, 20083 min read

Key points

  • Few women in the developing world are screened effectively for cervical cancer and those at highest risk of developing the disease are among the least likely to be screened, accordingly an analysis published in PLoS Medicine.
  • To address this lack of information and to estimate the magnitude of inequalities in access to screening services, Gakidou and colleagues analyzed World Health Organization surveys from 57 countries across all levels of economic development.
  • The findings also show a wide gap between those countries with the most effective cervical cancer screening programmes and those where little screening for cervical cancer takes place at all.
  • "Strategies for improving cervical cancer prevention must be adapted to meet the specific needs of individual countries," conclude the authors.

Few women in the developing world are screened effectively for cervical cancer and those at highest risk of developing the disease are among the least likely to be screened, accordingly an analysis published in PLoS Medicine. The study, by Emmanuela Gakidou (University of Washington, Seattle, USA) and colleagues, also finds striking inequalities in access to cervical cancer screening between and within countries.

Cervical cancer is the second-most common cancer in women and a leading cause of death worldwide. Since the 1970s, the developed world has seen a fall in the annual number of new cases of cervical cancer, and a fall in the death rate from the disease. This public health success is often credited to widespread screening programmes. But in the developing world, where most cervical cancer occurs, there is little information about rates of screening.

To address this lack of information and to estimate the magnitude of inequalities in access to screening services, Gakidou and colleagues analyzed World Health Organization surveys from 57 countries across all levels of economic development.

They calculated the results both in terms of effective coverage (the proportion of eligible women who had had a pelvic exam and a Pap smear test in the last three years) and crude coverage (the proportion of eligible women who reported they had just had a pelvic exam, regardless of when this occurred). By both measures the researchers found a huge disparity in rates of cervical cancer screening; in terms of effective coverage only 19% of women in the developing world have been screened compared to 63% in developed countries.

The findings also show a wide gap between those countries with the most effective cervical cancer screening programmes and those where little screening for cervical cancer takes place at all. For example, over 80% of women receive effective screening in Austria compared to 1% or less in Ethiopia and Bangladesh. In 16 of the 57 countries studied, most women have never had a pelvic exam and in Ethiopia, Malawi and Bangladesh, this is true of 90% of women.

The researchers found that poor women, who are likely to have higher exposure to cervical cancer risk factors such as smoking or unsafe sex, are less likely to get screened effectively. In developing countries as a whole, screening coverage rates also decline with advancing age, which is when cervical cancer incidence rates are known to be highest.

"Strategies for improving cervical cancer prevention must be adapted to meet the specific needs of individual countries," conclude the authors. "Expanded screening may be a viable option where sufficient infrastructure and health system access exists, but novel strategies need to be considered in other settings."

###

Citation: Gakidou E, Nordhagen S, Obermeyer Z (2008) Coverage of cervical cancer screening in 57 countries: Low average levels and large inequalities. PLoS Med 5(6): e132.

CONTACT:
Emmanuela Gakidou
University of Washington
Institute for Health Metrics and Evaluation
Seattle, WA 98121
United States of America
+1 206 897 2810
gakidou@u.washington.edu

Contact: Andrew Hyde
press@plos.org
01-223-463-330
Public Library of Science

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. Drug information pages are an archive and may be out of date: always follow your prescriber, your pharmacist and the current product label. In an emergency, call 911.

Keep reading

Brain

Italy court ruling links mobile phone use to tumor

Italy's supreme court has upheld a ruling that said there was a link between a business executive's brain tumor and his heavy mobile phone usage, potentially opening the door to further legal claims. The court's…

2 min read

When to get help

Reading is for later. These need care now.

Call 911 or go to an emergency department if you or someone with you has any of these:

  • Chest pain or pressureEspecially with breathlessness, sweating or pain in the arm, jaw or back. It can be a heart attack.
  • Face drooping, arm weakness, slurred speechSigns of a stroke. Note the time they started: treatment works best within hours.
  • Severe trouble breathingIncluding a severe allergic reaction with swelling of the lips, tongue or throat.
  • Thoughts of suicideCall or text 988 (Suicide & Crisis Lifeline, US) any time, day or night.

Outside the US, call your local emergency number.

See a doctor within days

  1. 01A new lump, or a sore that does not healMost lumps are harmless, but anything that grows or lasts more than a few weeks should be checked.
  2. 02Unexplained weight loss or lasting fatigueLosing weight without trying, or tiredness that does not lift, can have many causes worth finding.
  3. 03A new medicine and new symptomsSide effects and interactions are common. Ask your pharmacist or prescriber before you stop anything.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.